New drug trial aims to tame rare liver disease
Disease control
Recruiting now
This study tests a new drug, LB-P8, in 87 adults with primary sclerosing cholangitis (PSC), a rare liver disease. The goal is to see if LB-P8 is safe and can lower liver enzyme levels, which may help control the disease. Participants will receive either LB-P8 or a placebo, and re…
Phase: PHASE2 • Sponsor: LISCure Biosciences • Aim: Disease control
Last updated May 26, 2026 12:08 UTC